Header

UZH-Logo

Maintenance Infos

A novel germline mutation of PDGFR-β might be associated with clinical response of colorectal cancer to regorafenib


Rechsteiner, M; Wild, P; Kiessling, M K; Bohnert, A; Zhong, Q; Stahel, R A; Moch, H; Curioni-Fontecedro, A (2015). A novel germline mutation of PDGFR-β might be associated with clinical response of colorectal cancer to regorafenib. Annals of Oncology, 26(1):246-248.

Statistics

Citations

5 citations in Web of Science®
5 citations in Scopus®
Google Scholar™

Altmetrics

Downloads

20 downloads since deposited on 30 Oct 2014
16 downloads since 12 months
Detailed statistics

Additional indexing

Item Type:Journal Article, refereed, further contribution
Communities & Collections:04 Faculty of Medicine > University Hospital Zurich > Institute of Pathology and Molecular Pathology
04 Faculty of Medicine > University Hospital Zurich > Clinic for Oncology
Dewey Decimal Classification:610 Medicine & health
Language:English
Date:2015
Deposited On:30 Oct 2014 13:59
Last Modified:05 Apr 2016 18:27
Publisher:Oxford University Press
ISSN:0923-7534
Free access at:Publisher DOI. An embargo period may apply.
Publisher DOI:https://doi.org/10.1093/annonc/mdu471
PubMed ID:25336117

Download

Preview Icon on Download
Preview
Content: Accepted Version
Filetype: PDF
Size: 179kB
View at publisher

Author Collaborations